Investors / filer profile

Kumar Amit

Chief Executive Officer

active in 1 company · 1 of 1 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 12
Filings: 1
Companies: 2026-09-10
Last filed

EDGAR · CIK 0001191905 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+55.9%

median move per position

+12.2%

S&P 500 median, same spans

1 of 1

beat the S&P ~6mo later

1 position still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$191.1K bought

All filings on record

Every Form 4 transaction we track for this filer


ANIXAnixa Biosciences Inc	Buy $8.3K · 3,000 sh	2026-09-10	—
ANIXAnixa Biosciences Inc	Buy $13.8K · 5,000 sh	2026-09-10	—
ANIXAnixa Biosciences Inc	Buy $17.4K · 5,000 sh	2026-07-31	—
ANIXAnixa Biosciences Inc	Buy $17.2K · 5,000 sh	2026-07-27	—
ANIXAnixa Biosciences Inc	Buy $10.7K · 3,188 sh	2026-07-27	—
ANIXAnixa Biosciences Inc	Buy $11.2K · 3,000 sh	2026-07-24	—
ANIXAnixa Biosciences Inc	Buy $52.5K · 21,000 sh	2026-06-12	—
ANIXAnixa Biosciences Inc	Tax $687.9K · 169,439 sh	2025-10-30	—
ANIXAnixa Biosciences Inc	Exercise $584.0K · 200,000 sh	2025-10-30	—
ANIXAnixa Biosciences Inc	Buy $15.8K · 5,000 sh	2025-07-30	—

ANIXBuy

2026-09-10 · Anixa Biosciences Inc

$8.3K

—

ANIXBuy

2026-09-10 · Anixa Biosciences Inc

$13.8K

—

ANIXBuy

2026-07-31 · Anixa Biosciences Inc

$17.4K

—

ANIXBuy

2026-07-27 · Anixa Biosciences Inc

$17.2K

—

ANIXBuy

2026-07-27 · Anixa Biosciences Inc

$10.7K

—

ANIXBuy

2026-07-24 · Anixa Biosciences Inc

$11.2K

—

ANIXBuy

2026-06-12 · Anixa Biosciences Inc

$52.5K

—

ANIXTax

2025-10-30 · Anixa Biosciences Inc

$687.9K

—

ANIXExercise

2025-10-30 · Anixa Biosciences Inc

$584.0K

—

ANIXBuy

2025-07-30 · Anixa Biosciences Inc

$15.8K

—

Newest 10 of 12 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.